GOOS Canada Goose Holdings Inc.
Canada Goose Holdings Inc., together with its subsidiaries, designs, manufactures, and sells performance luxury outerwear, apparel, footwear, and accessories for men, women, youth, children, and babies. It operates through three segments: Direct-to-Consumer, Wholesale, and Other. The company offers leisure wear, including knitwear, sweats, and t-shirts; outerwear products, including rain and everyday collections, jackets for everyday occasions, fleece, and vests; footwear and accessories products, such as sneakers, boots, hats, scarves, gloves, hood trims, socks, bags and eyewear; and lightweight and heavyweight down jackets for the fall, winter, and spring seasons. It sells its products through e-commerce channels and directly operated retail stores. The company offers its products under Canada Goose, Snow Goose, and Baffin brands in Canada, the United States, North America, Greater China, rest of the Asia Pacific, Europe, the Middle East, and Africa. Canada Goose Holdings Inc. was founded in 1957 and is headquartered in Toronto, Canada.…
Industry Peers
Apparel ManufacturingKey Statistics
About Canada Goose Holdings (TSE: GOOS)
›
Canada Goose Holdings (TSE: GOOS) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Apparel Manufacturing industry, part of the Consumer Cyclical sector.
The shares were at 11.08 CAD on 19 November 2026, down 35.6% over 52 weeks. Its 52-week range is 10.31 CAD to 20.44 CAD: the price is 45.8% below the high and 7.5% above the low.
At a market capitalisation of 1.04B CAD, it trades at 20.5 times trailing earnings and 9.9 times forward earnings. The median trailing P/E of its 17 largest Apparel Manufacturing peers is 18.7, so GOOS is valued in line with them.
Canada Goose Holdings reports return on equity of 3.7%, an operating margin of 10.2% and revenue up 5.9% year over year.
Its debt exceeds its cash by 780.70M CAD, a debt-to-equity ratio of 1.29. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 8 analysts cover the stock, with an average rating of Hold; their mean price target of 13.16 CAD is 18.7% above the current price. The next earnings report is expected on 4 February 2027.